IBT
International Biotechnology Trust’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $10.3M | Buy |
40,200
+29,200
| +265% | +$7.51M | 3.48% | 8 |
|
2023
Q2 | $3.13M | Sell |
11,000
-10,400
| -49% | -$2.96M | 0.95% | 32 |
|
2023
Q1 | $5.95M | Hold |
21,400
| – | – | 1.66% | 21 |
|
2022
Q4 | $5.92M | Sell |
21,400
-24,100
| -53% | -$6.67M | 1.83% | 19 |
|
2022
Q3 | $12.1M | Buy |
45,500
+34,894
| +329% | +$9.32M | 3.9% | 6 |
|
2022
Q2 | $52K | Buy |
+10,606
| New | +$52K | 0.54% | 40 |
|
2022
Q1 | – | Sell |
-47,500
| Closed | -$11.4M | – | 73 |
|
2021
Q4 | $11.4M | Buy |
47,500
+22,000
| +86% | +$5.28M | 2.54% | 14 |
|
2021
Q3 | $7.21M | Sell |
25,500
-23,000
| -47% | -$6.5M | 1.74% | 19 |
|
2021
Q2 | $16.8M | Hold |
48,500
| – | – | 4.43% | 9 |
|
2021
Q1 | $13.6M | Buy |
48,500
+15,700
| +48% | +$4.39M | 3.59% | 12 |
|
2020
Q4 | $8.02M | Sell |
32,800
-10,800
| -25% | -$2.64M | 2.19% | 17 |
|
2020
Q3 | $12.3M | Sell |
43,600
-7,600
| -15% | -$2.15M | 3.99% | 10 |
|
2020
Q2 | $13.3M | Buy |
51,200
+5,500
| +12% | +$1.43M | 4.43% | 8 |
|
2020
Q1 | $14.5M | Hold |
45,700
| – | – | 6.59% | 3 |
|
2019
Q4 | $13.6M | Buy |
45,700
+14,000
| +44% | +$4.15M | 4.88% | 7 |
|
2019
Q3 | $7.38M | Sell |
31,700
-11,000
| -26% | -$2.56M | 3.41% | 11 |
|
2019
Q2 | $9.99M | Buy |
42,700
+33,200
| +349% | +$7.76M | 3.7% | 9 |
|
2019
Q1 | $2.25M | Sell |
9,500
-7,700
| -45% | -$1.82M | 0.83% | 36 |
|
2018
Q4 | $4.06M | Buy |
+17,200
| New | +$4.06M | 2.52% | 15 |
|
2018
Q3 | – | Sell |
-36,208
| Closed | -$10.5M | – | 52 |
|
2018
Q2 | $10.5M | Sell |
36,208
-9,400
| -21% | -$2.73M | 4.04% | 7 |
|
2018
Q1 | $12.5M | Sell |
45,608
-19,400
| -30% | -$5.31M | 4.87% | 5 |
|
2017
Q4 | $20.7M | Sell |
65,008
-6,500
| -9% | -$2.07M | 7.3% | 1 |
|
2017
Q3 | $22.4M | Buy |
71,508
+10,400
| +17% | +$3.25M | 8.71% | 2 |
|
2017
Q2 | $16.6M | Sell |
61,108
-14,300
| -19% | -$3.88M | 6.3% | 4 |
|
2017
Q1 | $20.6M | Buy |
75,408
+9,500
| +14% | +$2.6M | 7.89% | 2 |
|
2016
Q4 | $18.7M | Buy |
+65,908
| New | +$18.7M | 8.42% | 2 |
|